bioAffinity Technologies (BIAF) Receivables (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Receivables of $717732.0 for Q1 2026, down 26.85% year-over-year from $981125.0 in Q1 2025, and up 26.3% quarter-over-quarter from $568257.0 in Q4 2025.
bioAffinity Technologies (BIAF) Receivables (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Receivables for 6 consecutive years, with $717732.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 26.85% year-over-year to $717732.0; the TTM figure through Mar 2026 stood at $717732.0 (down 26.85% YoY), while the FY2025 annual figure was $568257.0, down 51.31% from the prior year.
- Receivables climbed to $717732.0 in Q1 2026 per BIAF's latest filing, from $568257.0 in the prior quarter.
- Across five years, Receivables topped out at $1.7 million in Q2 2024 and bottomed at $9930.0 in Q3 2022.
- Historically, Receivables has averaged $713956.7 across 5 years, with a median of $717732.0 in 2026.
- Annual changes were most pronounced in 2023 — Receivables jumped 11109.91% — and 2025, when it tumbled 74.26%.
- bioAffinity Technologies' Receivables stood at $20978.0 in 2022, then jumped by 3910.04% to $841227.0 in 2023, then surged by 38.74% to $1.2 million in 2024, then tumbled by 51.31% to $568257.0 in 2025, then gained by 26.3% to $717732.0 in 2026.
- Business Quant data shows BIAF's Receivables at $717732.0 in Q1 2026, $568257.0 in Q4 2025, and $476133.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 11.14 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 3.97 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 421.97 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.50 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.16 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 709.36 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 791.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 731.48 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.50 Bn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 914,123.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 914,123.00 |
| Mar 31, 2026 | 717,732.00 |
| Dec 31, 2025 | 568,257.00 |
| Sep 30, 2025 | 476,133.00 |
| Jun 30, 2025 | 441,385.00 |
| Mar 31, 2025 | 981,125.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 841,227.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 90,233.00 |
| Mar 31, 2023 | 11,027.00 |
| Dec 31, 2022 | 20,978.00 |
| Sep 30, 2022 | 9,930.00 |
| Dec 31, 2021 | 1,530.00 |